Sunita D. Srivastava, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 14 | 2022 | 1309 | 1.160 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 151 | 0.770 |
Why?
|
| Aortic Aneurysm, Abdominal | 10 | 2022 | 1154 | 0.740 |
Why?
|
| Authorship | 1 | 2022 | 270 | 0.700 |
Why?
|
| Physicians, Women | 2 | 2022 | 473 | 0.690 |
Why?
|
| Endovascular Procedures | 6 | 2022 | 1925 | 0.610 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2022 | 953 | 0.540 |
Why?
|
| Aneurysm | 3 | 2013 | 319 | 0.490 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1412 | 0.390 |
Why?
|
| Viscera | 1 | 2010 | 147 | 0.380 |
Why?
|
| Vascular Surgical Procedures | 5 | 2011 | 1451 | 0.360 |
Why?
|
| Carotid Artery Diseases | 2 | 2011 | 890 | 0.300 |
Why?
|
| Biomedical Research | 1 | 2022 | 3268 | 0.290 |
Why?
|
| Endoleak | 3 | 2015 | 97 | 0.270 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 551 | 0.260 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 624 | 0.260 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 1216 | 0.250 |
Why?
|
| Stents | 10 | 2011 | 3207 | 0.220 |
Why?
|
| Diverticulum | 1 | 2021 | 133 | 0.190 |
Why?
|
| Vascular Patency | 4 | 2010 | 841 | 0.190 |
Why?
|
| Anticoagulants | 2 | 2013 | 4375 | 0.190 |
Why?
|
| Device Removal | 2 | 2015 | 648 | 0.180 |
Why?
|
| Prosthesis Design | 4 | 2022 | 2103 | 0.180 |
Why?
|
| Angioplasty, Balloon | 3 | 2009 | 652 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 437 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 217 | 0.150 |
Why?
|
| Aortic Aneurysm | 2 | 2015 | 663 | 0.150 |
Why?
|
| Prosthesis Failure | 2 | 2013 | 1211 | 0.150 |
Why?
|
| Chordoma | 1 | 2020 | 383 | 0.150 |
Why?
|
| Free Tissue Flaps | 1 | 2020 | 286 | 0.150 |
Why?
|
| Iliac Artery | 2 | 2009 | 354 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3014 | 0.130 |
Why?
|
| Bone Transplantation | 1 | 2020 | 928 | 0.130 |
Why?
|
| Retrospective Studies | 12 | 2022 | 72443 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 829 | 0.110 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2009 | 782 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2020 | 953 | 0.110 |
Why?
|
| After-Hours Care | 1 | 2013 | 105 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1141 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 2360 | 0.100 |
Why?
|
| Splenic Artery | 1 | 2011 | 51 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2004 | 666 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1834 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 3 | 2011 | 481 | 0.100 |
Why?
|
| Emergencies | 2 | 2013 | 1122 | 0.100 |
Why?
|
| Life Tables | 1 | 2010 | 376 | 0.090 |
Why?
|
| Collateral Circulation | 1 | 2010 | 306 | 0.090 |
Why?
|
| Carotid Artery, Internal | 1 | 2011 | 461 | 0.090 |
Why?
|
| Aneurysm, False | 1 | 2011 | 281 | 0.090 |
Why?
|
| Treatment Outcome | 11 | 2022 | 62004 | 0.080 |
Why?
|
| Sex Factors | 2 | 2022 | 10666 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2013 | 527 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2013 | 6722 | 0.080 |
Why?
|
| Ohio | 3 | 2013 | 350 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2011 | 451 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1558 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3318 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2006 | 62 | 0.070 |
Why?
|
| Inguinal Canal | 1 | 2006 | 70 | 0.070 |
Why?
|
| Aortography | 3 | 2015 | 439 | 0.070 |
Why?
|
| Postoperative Complications | 6 | 2013 | 15079 | 0.070 |
Why?
|
| Time Factors | 12 | 2015 | 40875 | 0.070 |
Why?
|
| Humans | 29 | 2022 | 715777 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4272 | 0.070 |
Why?
|
| Foreign-Body Migration | 2 | 2004 | 226 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1474 | 0.070 |
Why?
|
| Aged | 16 | 2022 | 162448 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 100 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 480 | 0.060 |
Why?
|
| Robotics | 1 | 2010 | 851 | 0.060 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2003 | 46 | 0.060 |
Why?
|
| Female | 18 | 2022 | 377204 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2009 | 714 | 0.060 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2003 | 40 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2006 | 909 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 685 | 0.060 |
Why?
|
| Renal Artery | 1 | 2004 | 396 | 0.060 |
Why?
|
| Male | 18 | 2022 | 350324 | 0.050 |
Why?
|
| Risk Factors | 6 | 2022 | 70866 | 0.050 |
Why?
|
| Reoperation | 5 | 2013 | 4169 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1255 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 129 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2020 | 5623 | 0.050 |
Why?
|
| Angioplasty | 1 | 2003 | 374 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 20356 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 2032 | 0.050 |
Why?
|
| Warfarin | 1 | 2008 | 1476 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2158 | 0.040 |
Why?
|
| Aneurysm, Dissecting | 1 | 2003 | 641 | 0.040 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 58323 | 0.040 |
Why?
|
| Portal Vein | 1 | 2020 | 425 | 0.040 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2010 | 2115 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6552 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 2074 | 0.040 |
Why?
|
| Radiography | 2 | 2004 | 6978 | 0.040 |
Why?
|
| Middle Aged | 14 | 2020 | 214639 | 0.040 |
Why?
|
| Aspirin | 1 | 2008 | 3190 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2021 | 1029 | 0.030 |
Why?
|
| Equipment Safety | 2 | 2003 | 274 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2789 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2034 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 509 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 212266 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2677 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2003 | 10499 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 13215 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 39300 | 0.020 |
Why?
|
| Michigan | 1 | 2006 | 332 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2004 | 43 | 0.020 |
Why?
|
| Iliac Aneurysm | 1 | 2004 | 39 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3542 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 108 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2006 | 579 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 235 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2004 | 192 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 948 | 0.010 |
Why?
|
| Biomedical Technology | 1 | 2004 | 219 | 0.010 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 290 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2004 | 579 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 2843 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6267 | 0.010 |
Why?
|
| Angiography | 1 | 2006 | 1625 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5132 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13758 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 34430 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1511 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8240 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12456 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1879 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 1448 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4893 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5922 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6501 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3588 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 9030 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 15059 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 23464 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12480 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 13206 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 22665 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15199 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15909 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 80375 | 0.000 |
Why?
|
| United States | 1 | 2004 | 67905 | 0.000 |
Why?
|
| Animals | 1 | 2006 | 169420 | 0.000 |
Why?
|